相关实验视频

Updated: Jun 16, 2026

Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging

Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging

Published on: January 5, 2015

肝病光成像剂的合理设计:从分子机制到诊断精度

Yuantao Mao¹, Wen Zhang¹, Xin Wang¹

¹College of Chemistry, Chemical Engineering, and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institutes of Biomedical Sciences, Shandong Normal University, Jinan 250014, China. xinwang@sdnu.edu.cn.

Chemical Society reviews

|March 3, 2026

概括

光探针为脂肪肝和癌症等肝脏疾病提供敏感,特定的成像. 本综述详细介绍了探头开发和早期诊断和治疗的应用方面的最新进展.

科学领域:

生物医学成像技术生物医学成像技术
分子诊断学分子诊断学
肝病学肝病学是一种肝病学.

背景情况:

肝病是一个全球性的健康挑战,由分子和微环境失调驱动.
准确了解疾病机制和先进的检测技术对于有效管理至关重要.
光成像为肝病生物标志物的现场动态监测提供了高灵敏度和特异性.

研究的目的:

系统地审查最近 (2020年后) 对于肝脏疾病的光探针的进展.
概述这些探测器的设计原则,准策略和信号调节机制.
讨论脂肪肝疾病,急性肝损伤和肝细胞癌的应用以及未来的方向.

主要方法:

文献综述专注于自2020年以来的光探针开发和在肝脏疾病中的应用.
分析探头设计原则,生物标记物准和光学信号机制.
讨论生物成像研究及其在特定肝脏疾病中的发现.

主要成果:

在开发用于检测和可视化肝脏疾病的光探针方面取得了重大进展.
探测器在研究疾病机制和使早期诊断成为可能方面的实用性.
洞察探针激活机制和脂肪肝,急性肝损伤和HCC中的生物发现.

结论:

光探针是用于分子和细胞水平可视化肝脏疾病的强大工具.
持续开发高效和多功能探头将增强光成像应用.
这一领域对推进肝脏疾病的精确诊断和治疗策略充满希望.

更多相关视频

The Use of Ex Vivo Whole-organ Imaging and Quantitative Tissue Histology to Determine the Bio-distribution of Fluorescently Labeled Molecules

The Use of Ex Vivo Whole-organ Imaging and Quantitative Tissue Histology to Determine the Bio-distribution of Fluorescently Labeled Molecules

Published on: December 24, 2016

In Vivo Imaging of Transduction Efficiencies of Cardiac Targeting Peptide

In Vivo Imaging of Transduction Efficiencies of Cardiac Targeting Peptide

Published on: June 11, 2020

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...